If you experience these symptoms, discuss a dose reduction with your provider rather than simply pushing through
The MHRA approved tirzepatide following clinical trial data demonstrating improvements in glycaemic control and substantial weight reduction compared to placebo and other diabetes medications
July 27, 2026: FDA peptide panel narrowly votes to add unapproved drugs to compounding list Major Stories The FDAs peptide panel voted to add six unapproved compounds to the 503A bulks compounding list, despite agency scientists' warnings about the consequences
Advanced Cellular Technology: Pill and capsule Glutathione supplements are ineffective, as the Glutathione is destroyed during the digestion process
Backed by preclinical and clinical studies with human relevance
Rodents given GLP-1 agonists show reduced preference for alcohol, cocaine, opioids, and high-fat food